Tag: drug pricing

drug pricing

DTC Advertising

Despite Industry’s Price Transparency Initiatives, CMS Pushes Proposed Rule Forward

Despite Industry’s Price Transparency Initiatives, CMS Pushes Proposed Rule Forward

April 8, 2019 – The first television ads including drug price information are hitting the airwaves, reinforcing the point that list price is a highly misleading metric, and Pharmaceutical Research and Manufacturers of America (PhRMA) members are preparing to voluntarily refer consumers to online drug pricing information in their drug ads within a few weeks. […]

Read more

DTC Advertising

Trade Groups Say CMS Lacks Authority to Mandate Drug Prices in DTC TV Ads

Trade Groups Say CMS Lacks Authority to Mandate Drug Prices in DTC TV Ads

Jan. 15, 2019 – In comments to the Centers for Medicare and Medicaid Services (CMS) regarding its proposal to require that drug companies include the wholesale acquisition cost (WAC) of a drug in direct-to-consumer (DTC) television ads, industry trade groups and pharmaceutical companies largely are in agreement that doing so would confuse consumers, that CMS […]

Read more

DTC Advertising

CHC Cites Practical, Legal Concerns in Comment to CMS on Drug Prices in DTC Ads

CHC Cites Practical, Legal Concerns in Comment to CMS on Drug Prices in DTC Ads

Dec. 17, 2018 – The Coalition for Healthcare Communication (CHC) finds the recent proposal to require drug list prices in direct-to-consumer (DTC) television ads “detrimental to the interests of both health providers and patients,” and raises numerous practical and legal concerns to support that position in its official comment filed Dec. 14 with the Centers […]

Read more

Washington Focus

PhRMA’s Zirkelbach: New DTC Code Provides Information Consumers Really Want on Coverage

PhRMA’s Zirkelbach: New DTC Code Provides Information Consumers Really Want on Coverage

Dec. 10, 2018 – The Health and Human Services (HHS) proposal to require that drug companies include drug list prices in direct-to-consumer (DTC) ads could potentially confuse patients, and it also could cause patients to defer treatment because of the misleading price tag, according to Robert Zirkelbach, EVP of public affairs, Pharmaceutical Research and Manufacturers […]

Read more

Washington Focus

Midterms Delivered Divided Government, New Players

Midterms Delivered Divided Government, New Players

Nov. 30, 2018 – The 2018 midterm elections resulted in a divided Congress, questions about possible agency changes, and uncertainty related to drug pricing policy and the Affordable Care Act, according to Kate Rawson, senior editor, Prevision Policy and The RPM Report, who spoke at the Coalition for Healthcare Communication’s “2018 Post-election Conference on Healthcare […]

Read more

Washington Focus

Sen. Coons Opposes Compelling List Prices in DTC Ads

Sen. Coons Opposes Compelling List Prices in DTC Ads

Nov. 28, 2018 — When it comes to healthcare in the United States, “we’ve got a lot of work to do in promoting transparency, bringing down cost, and making sure we are tying reimbursement to value of care rather than quantity of care,” Sen. Chris Coons (D-Del.) told attendees of the Coalition for Healthcare Communication’s […]

Read more

DTC Advertising

Amendment to Fund Drug Prices in Ads Dropped to Avert Derailment of HHS Spending Bill

Amendment to Fund Drug Prices in Ads Dropped to Avert Derailment of HHS Spending Bill

Sept. 24, 2018 — With the amendment to fund the implementation of mandatory drug prices in consumer advertising stripped out of the spending bill to which it had been attached, the question of whether or how quickly this drug pricing mandate will move forward remains unclear. The amendment, from Sens. Dick Durbin (D-Ill.) and Charles […]

Read more

DTC Advertising

Senate and HHS Make Moves to Advance Mandatory Drug Prices in Consumer Ads

Senate and HHS Make Moves to Advance Mandatory Drug Prices in Consumer Ads

Aug. 24, 2018 – Yesterday was a one-two punch in the Trump administration’s effort to move forward a plan to require that drug manufacturers include drug prices in ads directed toward consumers, as the White House Office of Management and Budget (OMB) reviews a proposed rule from the Department of Health & Human Services (HHS) […]

Read more

Legislative

Azar Says FDA Has Authority to Require List Prices in Drug Ads

Azar Says FDA Has Authority to Require List Prices in Drug Ads

June 13, 2018 – At a Senate Committee on Health, Education, Labor & Pensions hearing on drug pricing held yesterday, Department of Health and Human Services (HHS) Secretary Alex Azar told the committee that it is his belief that “we have the authority to require list price disclosure in TV ads,” as proposed in the […]

Read more

DTC Advertising

Debate over Listing Drug Prices in Ads Continues

Debate over Listing Drug Prices in Ads Continues

May 21, 2018 – Since the Trump administration presented its proposal to lower drug pricing on May 11, both the trade and mainstream media have been discussing whether one provision – a request that the Department of Health & Human Services evaluate the inclusion of drug prices in consumer ads – really has legs. In […]

Read more